Vol 3, No 2 (2016) > Articles >

Antibiotic Sensitivity in Pseudomonas aeruginosa of Diabetic Patient’s Foot Ulcer

Pratiwi Apridamayanti, Khairunnisa Azani Meilinasary, Rafika Sari

 

Abstract:

Diabetes Mellitus (DM) patients are at risk to have the diabetic ulcer. A main reason for DM’s patient with ulcer complication to be treated and healed in hospital is caused by bacterial infection. One of many bacteria that infects diabetic ulcer is Pseudomonas aeruginosa. The effort to treat this infection is by using antibiotic. The use of antibiotic unfortunately, is often found in accurate causing the microbe resistance to occur. To choose the right antibiotic, it needs to test the antibiotic’s sensitivity towards Pseudomonas aeruginosa. The aim of this study is to determine the sensitivity of antibiotics against Pseudomonas aeruginosa. Sample used was taken from diabetic ulcers swab with grade III and IV Wagner. The identification of bacteria was managed using the biochemical test and staining Gram test. Antibiotic sensitivity was determined by Kirby Bauer method. Antibiotic found still sensitive towards Pseudomonas aeruginosa included ciprofloxacin, norfloxacin, imipenem, levofloxacin, meropenem, ceftriaxone, and cefotaxime. Whereas cefadroxil and amikacin were resistant towards Pseudomonas aeruginosa in diabetic ulcer grade III and IV Wagner. Antibiotics that can be used on the bacteria Pseudomonas aeruginosa in diabetic foot ulcer patients are ciprofloxacin norfloxacin, imipenem, levofloxacin, meropenem, ceftriaxone, and cefotaxime.

Keywords: antibiotika; luka diabetik; pseudomonas aeruginosa; antibiotic; diabetic ulcer; pseudomonas aeruginosa
Published at: Vol 3, No 2 (2016) pages: 80-87
DOI:

Full PDF Download

References


Aulia F, N. (2008) Pola Kuman Aerob dan Sensitifitas Gangren Diabetik. Thesis. Medan: Repository FK USU; 2008.

Frykberg R.G, Zgonis T, Armstrong D.G, Driver V.R, Giurini J.M, Kravitz R.M, et al. (2006) Diabetic Foot Disorders A Clinical Practice Guideline. The Journal of Foot an Ankle; 45(5): 1-49.

Manisha J, Mitesh PH, Nidhi SK, Modi DJ, Vegad MM. (2012) Spectrum of Microbial Flora in Diabetic Foot Ulcer And Antibiotic Sensitivity Pattern in Tertiary Care Hospital in Ahmedabad, Gujarat : National Journal of Medical. Research. Vol 3: 354-57.

Meletis G, Bagkeri M. (2013) Pseudomonas aeruginosa:Multi-Drug-Resistance Development and Treatment Options. Greece: Licensee Intech.

Mayasari E. (2006) Pseudomonas aeruginosa: Karakteristik, Infeksi dan Penanganan. Medan: USU Repository.

PERKENI. (2011). Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus Tipe 2 di Indonesia. Jakarta : FKUI RSCM.

Sari R, Apridamayanti P. (2015) Identifikasi Bakteri Penghasil ESBL pada Penderita Ulkus Diabetikum Derajat III dan IV Wagner. Pontianak : Laporan Penelitian DIPA Universitas Tanjungpura.

Setiabudy R. Farmakologi dan Terapi. (2011) Jakarta: Department of Pharmacology and Therapeutic of Medical Faculty Universitas Indonesia.

Sulistiyaningsih. (2010) Uji Kepekaan Beberapa Sediaan Antiseptik Terhadap Bakteri Pseudomonas aeruginosa Dan Pseudomonas aeruginosa Multi Resisten (PAMR). Jatinangor: Independent Research Report.

Tambunan M. Perawatan Kaki Diabetes. (2007) Dalam: Soegondo S, dkk : Penatalaksanaan Diabetes Melitus Terpadu. Jakarta: Balai Penerbit FKUI.

Wid S, Roglic G, Green A, Sicree R, King H. (2004) Global Prevalence of Diabetes. Edinburgh: Diabetes Care; 27(5): 1050-1051.